Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease
The FASEB Journal · 28.02.2025 · 39 (4)
DOI: 10.1096/fj.202500030r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 25.02.2025. Verfasst von Chenggong Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Di…. Hauptthemen laut MEDLINE: Core Binding Factor beta Subunit, Cell Differentiation, Bone Development, Mesenchymal Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang Qianjiang Talent Program, Fundamental Research Funds of Zhejiang Sci-Tech University.
Abstract (Originalsprache)
The skeletal system comprises closely related yet functionally distinct bone and cartilage tissues, regulated by a complex network of transcriptional factors and signaling molecules. Among these, core‐binding factor subunit beta (Cbfβ) emerges as a critical co‐transcriptional factor that stabilizes Runx proteins, playing indispensable roles in skeletal development and homeostasis. Emerging evidence from genetic mouse models has highlighted the essential role of Cbfβ in directing the lineage commitment of mesenchymal stem cells (MSCs) and their differentiation into osteoblasts and chondrocytes. Notably, Cbfβ deficiency is strongly associated with severe skeletal dysplasia, affecting both endochondral and intramembranous ossification during embryonic and postnatal development. In this review, we synthesize recent advancements in understanding the structural and molecular functions of Cbfβ, with a particular focus on its interactions with key signaling pathways, including BMP/TGF‐β, Wnt/β‐catenin, Hippo/YAP, and IHH/PTHrP. These pathways converge on the Cbfβ/RUNX2 complex, which orchestrates a gene expression program essential for osteogenesis, bone formation, and cartilage development. The integration of these signaling networks ensures the precise regulation of skeletal development, remodeling, and repair. Furthermore, the successful local delivery of Cbfβ to address bone abnormalities underscores its potential as a novel therapeutic target for skeletal disorders such as cleidocranial dysplasia, osteoarthritis, and bone metastases. By elucidating the molecular mechanisms underlying Cbfβ function and its interactions with key signaling pathways, these insights not only advance our understanding of skeletal biology but also offer promising avenues for clinical intervention, ultimately improving outcomes for patients with skeletal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics, Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Science and Medicine, Zhejiang Sci-Tech Univer…
- Department of Orthopedics, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
ORCID-Profile: Chenggong Zheng, Chenyang Zhang, Yiliang He, Sisi Lin, Zhenya Zhu, Haidong Wang, Guiqian Chen
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Qianjiang Talent Program
- Fundamental Research Funds of Zhejiang Sci-Tech University
- National Natural Science Foundation of China
Zitieren
APA
Zheng, C., Zhang, C., He, Y., Lin, S., Zhu, Z., Wang, H., & Chen, G. (2025). Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease. The FASEB Journal, 39(4). https://doi.org/10.1096/fj.202500030r
Vancouver
Zheng C, Zhang C, He Y, Lin S, Zhu Z, Wang H, et al. Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease. The FASEB Journal. 2025;39(4). doi:10.1096/fj.202500030r
BibTeX
@article{Zheng2025,
author = {Zheng, Chenggong and Zhang, Chenyang and He, Yiliang and Lin, Sisi and Zhu, Zhenya and Wang, Haidong and Chen, Guiqian},
title = {Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {4},
doi = {10.1096/fj.202500030r}
}
EUVIMED